top of page
News
Chat
Insights
Portfolios
Education
About
Pricing
BPIQ API
BPIQ APEX
SUPN Reports Mixed Results in ADHD
SUPN reported mixed positive results today for its final phase 3 trial for SPN-812 in attention deficit hyperactivity disorder (ADHD).*...
Mar 28, 2019
2 min read
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
